Bristol Myers Squibb Company (BMY) Is a Trending Stock: Facts to Know Before Betting on It

Bristol Myers Squibb (BMY) has been a trending stock but faces headwinds with shares down 11.1% over the past month. While the company maintains a Zacks Rank #3 (Hold) rating and trades at a valuation discount to peers, earnings estimates have declined 3.6% over the last 30 days. The company has a strong track record of beating consensus estimates but faces modest revenue growth projections of 3.4% for the current fiscal year.